Market Trends of Endoscopic Vessel Harvesting Industry
The Coronary Artery Disease Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period
Coronary artery disease (CAD) is a narrowing or blockage of coronary arteries, usually due to plaque buildup. The rising prevalence of coronary artery disease (CAD) and the rising geriatric population are driving the growth of the segment.
According to an article published by PubMed Central in July 2022, coronary artery disease, also known as coronary heart disease, is often caused by decreased myocardial perfusion that causes issues such as angina, myocardial infarction (MI), and heart failure. CADs account for one-third to half of all cardiovascular diseases. Thus, due to the high burden of coronary artery disease, the segment is expected to experience growth during the forecast period.
According to an article reviewed by Healthdirect Australia in June 2022, coronary heart disease was the most common cause of death in Australia, and risk factors for this included smoking, excessive alcohol consumption, lack of exercise, social isolation, and being overweight or obese. Thus, the high burden of CAD in various countries is expected to boost the adoption of endoscopic vessel harvesting procedures for its treatment.
The increasing risk of CAD with increasing age and the rising geriatric population globally are other major factors driving segment growth. For instance, according to an article updated by NCBI in November 2022, the incidence of CAD rises with age, regardless of gender. Additionally, the increasing investment in CAD research is expected to introduce advanced endoscopic vessel harvesting procedures to the market.
Thus, factors such as the rising burden of CAD, the increasing geriatric population, and the increasing investment in research for CAD are expected to boost segmental growth.
North America Holds the Largest Share of the Market Over the Forecast Period
North America is expected to hold a significant share of the market due to the rising burden of diseases such as coronary artery disease and peripheral arterial disease, coupled with the rising geriatric population and product launches by key market players.
According to the data published by Statistics Canada in July 2022, it was estimated that around 7,330,605 people were aged 65 years or older in Canada, accounting for 18.8% of the total population. As the geriatric population is more prone to peripheral arterial diseases, the rising geriatric population is expected to increase the demand for endoscopic vessel harvesting procedures, thereby driving market growth in the region.
The high burden of coronary artery disease in the United States, as highlighted in a May 2024 article from Current Problems in Cardiology, stood at 4.9% among US adults in 2022. This significant burden of CADs directly fuels market growth.
The entry of new players in the region also drives the growth of the market. For instance, in August 2022, CardioPrecision introduced its CoreVista devices for Endoscopic Vessel Harvesting (EVH) to the US market.
Thus, factors such as the rising burden of CAD and PAD and the increasing geriatric population are expected to boost segmental growth.
